Baker Biotech Capital II (GP), LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital II (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital II (GP), LLC. Baker Biotech Capital II (GP), LLC is a 10% Owner in VIROPHARMA INC ($VPHM) and a Director in SEATTLE GENETICS INC /WA ($SGEN).
Address: 667 MADISON AVENUE NEW YORK 10021 NY
Companies in which Baker Biotech Capital II (GP), LLC is an Insider
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital II (GP), LLC: Director
Holdings: 353,150 shares
Current Value: $21,467,989
Latest Transaction: May 06 2005
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VIROPHARMA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital II (GP), LLC: 10% Owner
Holdings: 5,735 shares
Latest Transaction: May 12 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Baker Biotech Capital II (GP), LLC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (GP), ... | 10% Owner | Option Exercise | P | 2.50 | 134,000 | 335,000 | 5,101,000 | |
| May 12 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (GP), ... | 10% Owner | Buy | P | 2.65 | 322 | 854 | 5,735 | 5.4 K to 5.7 K (+5.95 %) |
| May 12 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (GP), ... | 10% Owner | Buy | P | 1.79 | 2,620 | 4,689 | 5,413 | 2.8 K to 5.4 K (+93.81 %) |
| May 04 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (GP), ... | 10% Owner | Option Exercise | P | 109.15 | 397,000 | 43,332,550 | 1,598,000 | |
| May 06 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital II (GP), ... | Director | Buy | P | 4.79 | 6,627 | 31,741 | 353,150 | 346.5 K to 353.2 K (+1.91 %) |
| May 04 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital II (GP), ... | Director | Buy | P | 4.00 | 79,950 | 319,800 | 346,523 | 266.6 K to 346.5 K (+29.99 %) |
| May 04 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital II (GP), ... | Director | Buy | P | 3.99 | 1,186 | 4,730 | 266,573 | 265.4 K to 266.6 K (+0.45 %) |
View all Baker Biotech Capital II (GP), LLC insider transactions.